LN&Planting (N=53) |
Other (N=46) |
P-value | |
---|---|---|---|
Age (years) | |||
Mean (SD) | 55.5 (9.75) | 54.6 (10.8) | 0.474 |
Median [Min, Max] | 56.0 [24.0, 79.0] | 53.0 [28.0, 82.0] | |
Operation_history | |||
Direct_surgery | 29 (54.7%) | 37 (80.4%) | 0.00856 |
Septal_tumor_reduction | 0 (0%) | 1 (2.2%) | |
Surgery_after_neoadjuvant | 24 (45.3%) | 8 (17.4%) | |
Type | |||
CCC | 1 (1.9%) | 1 (2.2%) | 0.339 |
EC | 1 (1.9%) | 2 (4.3%) | |
HGSC | 48 (90.6%) | 41 (89.1%) | |
LGSC | 2 (3.8%) | 0 (0%) | |
MC | 0 (0%) | 2 (4.3%) | |
Missing | 1 (1.9%) | 0 (0%) | |
Clinical_stage | |||
I | 0 (0%) | 1 (2.2%) | <0.001 |
II | 0 (0%) | 8 (17.4%) | |
III | 19 (35.8%) | 26 (56.5%) | |
IV | 34 (64.2%) | 11 (23.9%) | |
Planting_metastasis | |||
No | 0 (0%) | 7 (15.2%) | 0.0107 |
Yes | 53 (100%) | 39 (84.8%) | |
Lymph.node_metastasis | |||
No | 0 (0%) | 41 (89.1%) | <0.001 |
Yes | 53 (100%) | 5 (10.9%) | |
TMB_group | |||
High | 3 (5.7%) | 2 (4.3%) | 1 |
Low | 48 (90.6%) | 44 (95.7%) | |
Missing | 2 (3.8%) | 0 (0%) | |
Relapse_within_6months | |||
Yes | 8 (15.1%) | 5 (10.9%) | 0.623 |
No | 35 (66.0%) | 29 (63.0%) | |
Unknown | 10 (18.9%) | 12 (26.1%) |